Botanical species · safety record

Artemisia abrotanum

The EFSA Compendium of Botanicals holds 23 constituent measurements for Artemisia abrotanum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia abrotanum L.

23Constituent measurements
0Safety records
8Cited sources
9Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 9 licensed products naming Artemisia abrotanum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Flowering aerial part(s)
  • Fresh young shoots and leaves
  • Jeunes pousses fraîches et feuilles
  • Partie aérienne fleurie fraîche

What the records describe

Constituents measured

  • 1,8-cineole6
  • (-)-camphor2
  • Camphor2
  • Isofraxidin2
  • Scopoletin2
  • Artemisinin1
  • Ascaridol1
  • Coumarins1
  • Esculetin1
  • Herniarin1

Plant parts

  • Aerial part of plants19
  • Leaves3
  • Unspecified1

Preparations

  • Solvent extraction13
  • Essential oil10

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
(-)-camphorAerial part of plantsEssential oil3.5 Percent AreaGC-FID-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil24.5 Percent AreaGC-FID-MSResolve DOI
EsculetinAerial part of plantsSolvent extractionHPLC-DADResolve DOI
HerniarinAerial part of plantsSolvent extractionHPLC-DADResolve DOI
IsofraxidinAerial part of plantsSolvent extractionHPLC-DADResolve DOI
ScopoletinAerial part of plantsSolvent extractionHPLC-DADResolve DOI
UmbelliferoneAerial part of plantsSolvent extractionHPLC-DADResolve DOI
(-)-camphorAerial part of plantsSolvent extraction3.5 Percent AreaGC-MSNo resolvable identifier
1,8-cineoleAerial part of plantsEssential oil12.54 Percent AreaGC-MSNo resolvable identifier
1,8-cineoleAerial part of plantsEssential oil≥ 15.46 Percent AreaUnspecifiedNo resolvable identifier
1,8-cineoleAerial part of plantsEssential oil≤ 33.19 Percent AreaUnspecifiedNo resolvable identifier
1,8-cineoleAerial part of plantsSolvent extraction10.5 Percent AreaGC-MSNo resolvable identifier
1,8-cineoleLeavesEssential oil4.3 Percent AreaGC-FID-MSNo resolvable identifier
ArtemisininUnspecifiedSolvent extraction0.0115 PercentLC-MSNo resolvable identifier
AscaridolAerial part of plantsSolvent extraction13.1 Percent AreaGC-MSNo resolvable identifier
CamphorAerial part of plantsEssential oil≥ 20.33 Percent AreaUnspecifiedNo resolvable identifier
CamphorAerial part of plantsEssential oil≤ 44.63 Percent AreaUnspecifiedNo resolvable identifier
CoumarinsLeavesSolvent extractionUnspecifiedNo resolvable identifier
IsoascaridoleAerial part of plantsSolvent extraction2.1 Percent AreaGC-MSNo resolvable identifier
IsofraxidinAerial part of plantsSolvent extraction3.3 Percent AreaGC-MSNo resolvable identifier
L-piperitoneAerial part of plantsEssential oil17.51 Percent AreaGC-MSNo resolvable identifier
Monoterpene ketonesLeavesEssential oil2.7 Percent AreaGC-FID-MSNo resolvable identifier
ScopoletinAerial part of plantsSolvent extraction2.1 Percent AreaGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kowalski, Radoslaw., Wawrzykowski, Jacek., Zawislak, Grazyna. Analysis of essential oils and extracts from Artemisia abrotanum L. and Artemisia dracunculus L. Herba polonica, 2007, vol. 53, no. 3, p. 246-254.
  2. Obistioiu, Diana., Cristina, Romeo T., Schmerold, Ivo., Chizzola, Remigius., Stolze, Klaus., Nichita, Ileana., Chiurciu, Viorica. Chemical characterization by GC-MS and in vitro activity against Candida albicans of volatile fractions prepared from Artemisia dracunculus, Artemisia abrotanum, Artemisia absinthium and Artemisia vulgaris . Chemistry central journal, 2014, vol. 8. DOI
  3. Radulovic, Niko S., Blagojevic, Polina D., Zlatkovic, Bojan K., Palic, Radosav M. A GC/MS Profile of the Volatile Constituents of the Aerial Parts of Artemisia abrotanum L. (Asteraceae) from Serbia . South african journal of chemistry-suid-afrikaanse tydskrif vir chemie, 2009, vol. 62, p. 30-32.
  4. Paszkiewicz, Monika., Orlita, Aleksandra., Dziabas, Alicja., Golebiowski, Marek., Lojkowska, Ewa., Szafranek, Janusz., Malinski, Edmund., Stepnowski, Piotr. Simplex optimized LC analysis of plant coumarins and furanocoumarins. Chromatographia, 2008, vol. 67, no. 7-8, p. 653-657. DOI
  5. Khodakov, G. V., Kotikov, I. V., Pankovetskii, V. N. COMPONENT COMPOSITION OF ESSENTIAL OIL FROM Artemisia abrotanum AND A. dracunculus . Chemistry of natural compounds, 2009, vol. 45, no. 6, p. 905-908.
  6. Pino, J. A., Marbot, R., Pilar Marti, M. Leaf Oil of Artemisia abrotanum L. Grown in Cuba. Journal of essential oil research, 2011, vol. 23, no. 1, p. 119-120.
  7. Suresh, J., Mruthunjaya, K., Paramakrishnan, N., Naganandhini, M. N. Determination of Artemisinin in Artemisia abrotanum and Artemisia pallens by LC/MS method. International journal of current pharmaceutical research, 2011, vol. 3, no. 1, p. 49-52.
  8. Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. Pectachol (HMDB39064).. Human metabolome database, 2012, vol. 3.0.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue